Australia's most trusted
source of pharma news
Sunday, 26 October 2025
Sunday, 26 October 2025
Subscribe
Login
News Headlines
News Headlines
News
First funded drug for fatal disease
Posted 23 October 2025 AM
Patients living with a devastating genetic disease gained access to funded treatment at the start of October for the first time in Australia.
Minister for Health, Disability, and Aged Care, Mark Butler, today announced that Sanofi's Xenpozyme is funded through the Life Saving Drugs Program (LSDP) as the first and only effective treatment approved for Australians with Acid Sphingomyelinase Deficiency (ASMD) in children and adult patients with type A/B (Niemann-Pick type A/B) or type B (Niemann-Pick type B).
To see the whole article, please login
Posted 23 October 2025 AM
Patients living with a devastating genetic disease gained access to funded treatment at the start of October for the first time in Australia.
Minister for Health, Disability, and Aged Care, Mark Butler, today announced that Sanofi's Xenpozyme is funded through the Life Saving Drugs Program (LSDP) as the first and only effective treatment approved for Australians with Acid Sphingomyelinase Deficiency (ASMD) in children and adult patients with type A/B (Niemann-Pick type A/B) or type B (Niemann-Pick type B).
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (4)
- Brand Manager - Melbourne
- Senior Product Manager - Sydney
- Associate Brand Manager - Sydney
- Associate Brand Manager - Sydney
Sales & Customer Relations (13)
- Customer Service Representative - Macquarie Park
- GP Sales Representative - NSW Mid North Coast - AstraZeneca - NSW
- GP Sales Representative - Cronulla - AstraZeneca - Cronulla, NSW
- Key Account Manager - Melbourne
- GP Sales Representative - Brisbane North - Flexible 3 Days - AstraZeneca - Brisbane
- GP Sales Representative - Sydney
- Customer Service Representative - St Leonards
- GP Sales Representative - Bundaberg, QLD - AstraZeneca - Bundaber, QLD
- GP Sales Representative - Adelaide South - AstraZeneca - Adelaide, SA
- Key Account Manager - Renal Metabolic - Adelaide - AstraZeneca - Adelaide, SA
- Territory Manager - Melbourne
- Customer Service Representative - Macquarie Park
- Inside Sales - Sydney
Clinical & Medical, R&D (6)
- QC Scientist - 40120 - Broadmeadows
- Medical Director - Sydney
- QCE Scientist Instrumentation (GDIP) - Broadmeadows
- Medical Advisor - Sydney
- Medical Advisor - Sydney
- Clinical Specialist - Sydney
Regulatory, Pharmacovigilance & QA (1)
Other (11)
- Warehouse & Logistics Officer - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Financial Analyst - Melbourne
- Senior Manager - Cell Therapy - Australia - AstraZeneca - Sydney or Melbourne
- Finance Business Partner - Surry Hills
- Logistics Specialist - Macquarie Park
- Senior Recruitment Consultant - Victoria
- Senior Recruitment Consultant - Sydney
- Financial Analyst - Melbourne
- Warehouse Assistant - Macquarie Park
- Financial Reporting Manager - Macquarie Park
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.